FINWIRES · TerminalLIVE
FINWIRES

$IMRN

4 stories mentioning IMRNUpdated just now

Every FINWIRES story that references IMRN, newest first.

Sectors

Sector Update: Healthcare Stocks Decline Late Afternoon

Healthcare stocks were lower late Friday afternoon, with the NYSE Healthcare Index falling 1.2% and the State Street Health Care Select Sector SPDR ETF (XLV) shedding 1.1%.The iShares Biotechnology ETF (IBB) was down 1%.In corporate news, Bristol Myers Squibb (BMY) told regulators, researchers and patient groups in early June that it had paused trials of its CAR-T treatment zola-cel in autoimmune disorders over potentially life-threatening side effects, The Wall Street Journal reported. Bristol Myers Squibb shares were falling 2%.Novo Nordisk's (NVO) charitable foundation and its Quantum Foundry Copenhagen company are planning to set up a new 5,300 square meter quantum chip production facility in Copenhagen, the organizations said. Novo shares were down 2.2%.Immuron (IMRN) shares surged 57% after it said Friday it has signed an exclusive distribution agreement with Sweden's Calmino Group to launch PROIBS, a digestive-health medical device used for abdominal pain and bloating.Tarsus Pharmaceuticals (TARS) shares rose past 9% after the company said it has completed its acquisition of retinal disease-focused biotech Alkeus Pharmaceuticals.

$BMY$IMRN$NVO$TARS
Wire

Immuron Signs Exclusive US Distribution Deal for Digestive-Health Product PROIBS

Immuron (IMRN) said Friday it has signed an exclusive distribution agreement with Sweden's Calmino Group to launch PROIBS, a digestive-health medical device used for abdominal pain and bloating.Financial details weren't disclosed.Immuron shares jumped 50% in Friday trading as intraday volume topped 108.1 million shares, compared with the daily average of 33,558.Price: $1.67, Change: $+0.56, Percent Change: +50.45%

$IMRN
Sectors

Sector Update: Healthcare Stocks Decline Friday Afternoon

Healthcare stocks were lower Friday afternoon, with the NYSE Healthcare Index and the State Street Health Care Select Sector SPDR ETF (XLV) each shedding 1.1%.The iShares Biotechnology ETF (IBB) was down 1%.In corporate news, Bristol Myers Squibb (BMY) told regulators, researchers and patient groups in early June that it had paused trials of its CAR-T treatment zola-cel in autoimmune disorders over potentially life-threatening side effects, The Wall Street Journal reported. Bristol Myers Squibb shares were falling 2.2%.Novo Nordisk's (NVO) charitable foundation and its Quantum Foundry Copenhagen company are planning to set up a new 5,300 square meter quantum chip production facility in Copenhagen, the organizations said. Novo shares were down 2.1%.Intellia Therapeutics (NTLA) shares added 0.8% after it said Friday it entered a $400 million non-dilutive senior secured term loan facility with OrbiMed to support clinical and commercial milestones.Immuron (IMRN) shares surged 41% after the company announced Friday an exclusive distribution agreement for Probis in the US with Calmino.

$BMY$IMRN$NTLA$NVO
Wire

Top Midday Gainers

American Outdoor Brands (AOUT) swung to a profit and posted higher revenue for fiscal Q1 late Thursday.Shares soared 41% as intraday trading volume catapulted to over 3.45 million from a daily average of about 104,000.Immuron (IMRN) shares jumped 48% amid heavy trading after the company announced Friday an exclusive distribution agreement for Probis in the US with Calmino Group.More than 105.4 million shares traded intraday compared with a daily average of about 34,000.Price: $1.62, Change: $+0.51, Percent Change: +45.50%

$AOUT$IMRN

Track with the FINWIRES app suite